Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about PTGX

Recent news which mentions PTGX

< Previous 1 2 3 4 Next >

Mid-Day Market Update: Nasdaq Down 400 Points; Arch Resources Shares Jump

April 26, 2022

34 Stocks Moving In Tuesday's Mid-Day Session

April 26, 2022

Mid-Morning Market Update: Markets Open Lower; Dow Dips 300 Points

April 26, 2022

Why Protagonist Therapeutics Shares Are Crashing Today

April 26, 2022

The Daily Biotech Pulse: Protagonist's Ulcerative Colitis Study Disappoints, Gilead's Remdesivir Approved For Pediatric COVID-19 Patients, FDA Gives Nod To Gamida's Cell Therapy Trial, Fast Track Tag

April 26, 2022

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

April 26, 2022

18 Stocks Moving in Tuesday's Pre-Market Session

April 26, 2022

Protagonist Therapeutics Topline Data from Phase 2 IDEAL Study of PN-943 (450 mg BID) Miss Primary Endpoint

April 25, 2022

12 Health Care Stocks Moving In Wednesday's After-Market Session

April 20, 2022

51 Biggest Movers From Thursday

April 18, 2022

12 Health Care Stocks Moving In Thursday's Intraday Session

April 14, 2022

The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More

April 14, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

April 14, 2022

FDA Intends To Revoke Protagonist Therapeutics' Rusfertide Breakthrough Tag In Rare Form Of Blood Cancer

April 14, 2022

Protagonist Therapeutics Earns $25M Milestone Payment From Janssen Biotech

March 16, 2022

Protagonist Therapeutics's Return On Capital Employed Overview

March 03, 2022

3 Desirable Drug Stocks With Very Promising Pipelines

February 16, 2022

The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More

December 06, 2021

Protagonist To Go Ahead With Oral Peptide PN-235, Discontinues Phase 1 Candidate

December 03, 2021

The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering

December 03, 2021

What 9 Analyst Ratings Have To Say About Protagonist Therapeutics

November 15, 2021

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More

November 08, 2021

Why Protagonist Therapeutics Stock Skyrocketed 80.2% Last Month

November 08, 2021

5 Short Squeeze Candidates To Watch: Progenity Tops List Again, Augmented Reality Play WiMi Hologram Joins List

November 01, 2021

Short Squeeze Stocks: PTGX, AGC and 3 Others Experts Think Are Ready to Pop

October 25, 2021

5 Short Squeeze Candidates To Watch: Progenity, Digital Brands Top List Again, SPAC AGC Joins Ahead Of Merger

October 25, 2021

The Daily Biotech Pulse: Athira CEO Resigns Over Doctored Research, Merck's Keytruda Snags First Approval For Breast Cancer In Europe, Minerva And Xilio IPOs

October 22, 2021

The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs

October 18, 2021

Ten stocks worth watching next week

October 16, 2021

What 10 Analyst Ratings Have To Say About Protagonist Therapeutics

October 13, 2021

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.